Loading...
Loading...
Algernon Health Inc.
Algernon Health Inc.. Spoken Alpha tracks AGNPF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AGNPF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AGNPF.
curl https://api.spokenalpha.com/v1/companies/AGNPF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.27 | $3.18 | -28.6% | +8.3% | +5.9% |
| Q4 FY2026 | $2.25 | $3.21 | -29.8% | +6.1% | +3.1% |
| Q3 FY2026 | $2.61 | $3.25 | -19.6% | +2.8% | +0.9% |
| Q2 FY2026 | $2.65 | $3.20 | -17.3% | +1.7% | +1.7% |
| Q1 FY2025 | $2.46 | $3.05 | -19.4% | +0.7% | -0.6% |
| Q4 FY2025 | $2.58 | $3.20 | -19.4% | -0.4% | -2.7% |
| Q3 FY2025 | $2.43 | $3.19 | -23.9% | +0.6% | +1.0% |
| Q2 FY2025 | $2.66 | $3.32 | -19.8% | -1.3% | -1.9% |
| Q1 FY2024 | $2.45 | $3.18 | -22.9% | -1.9% | -2.3% |
| Q4 FY2024 | $2.43 | $3.36 | -27.8% | +4.1% | +2.7% |